Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Feb 26, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the use of a special laser treatment, called photobiomodulation, to help reduce pain and inflammation in patients who have had lower back surgery, specifically spinal fusion or decompression. After these surgeries, some patients may develop chronic lower back pain, and while there are existing treatments like medications and physical therapy, this study is looking at whether high-power laser lights can offer additional relief. Participants will be divided into two groups: one will use a back brace equipped with the laser treatment, while the other will use a standard brace that doesn’t provide the laser treatment, acting as a comparison.
To be eligible for this trial, you must be over 18 years old and have had lower back surgery within the last 1 to 5 years, experiencing pain for more than three months with a pain level of at least 4 out of 10. The study is currently recruiting participants, and it is open to all genders. Throughout the trial, participants will also have their surgical wounds monitored to see how well they are healing while using the brace. If you have certain medical conditions or a history of drug misuse, you may not be able to participate, but if you meet the criteria, this trial could be a chance to explore a new treatment for your back pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject will have undergone minimally invasive spinal fusion surgery or spinal decompression surgery in their lower back L1-S1.
- • Have low back pain of \>3 months and a pain threshold of \> 4 (as described by the the subject), age \> 18 years, and English speaking to eliminate possible miscommunication and consequent human error regarding belt use.
- • Subject must have had surgery at minimum to 1 year prior to start of study and no more than 5 years prior to start to study
- Exclusion Criteria:
- • Patients with tumors
- • Current infection
- • Drug misuse history
- • Skin conditions preclude the use of laser belt
- • Severe spondylolisthesis, spondylolysis, spinal stenosis, ankylosing spondylitis
- • Previous low back surgery exceeding 5 years to initial start date.
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Los Angeles, California, United States
Patients applied
Trial Officials
Sara K Chung, PA
Study Director
University of California, Los Angeles
Sandra M Holley, PhD
Study Director
University of California, Los Angeles
Sichen Li, PhD
Study Director
University of California, Los Angeles
Adreanne Rivera, BS
Study Director
University of California, Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported